Hi All, ZLD is to float tomorrow, thought I would quickly...

Hi All,

ZLD is to float tomorrow, thought I would quickly summarise a few things for all the holders & non-holders who are showing interests,
will update the FA summary alone with the progress & news flow our company will be making in the coming weeks/months.
Lets beginning the topic by summarising what we have known so far, best of luck to all my fellows.


About Zeld

Zelda Therapeutics is a private California-based biotechnology company focused on medical cannabis therapies with a strong Australian connection, it was a spun-out of a successful US-based medicinal cannabis group - Aunt Zelda’s - that has treated hundreds of patients in California.

The company has exclusive, global access to an extensive set of human data related to medicinal cannabis-based formulations and treatment protocols. This human data has been generated over several years by the Aunt Zelda’s group.

Aunt Zelda’s has a very high profile within the U.S. and a growing international profile based upon its deep knowledge of the scientific rationale for certain cannabis-based formulations and protocols to treat a variety of medical conditions.

Zelda has been granted a worldwide, exclusive and perpetual licence to this data, related systems, formulations and treatment protocols by the Aunt Zelda’s group. Zelda will use this information to design a series of Phase 2-ready human clinical trials which the company is confident will be successful given the existing patient experiences and treatment outcomes.



Board of Directors




Medical Advisory Board

Zelda has attracted some of the world’s leading clinicians and researchers in the medicinal cannabis field to form Zelda’s Medical Advisory Board. The role of the Medical Advisory Board is to help guide and inform Zelda’s research and clinical activities.


Broad medical opportunities for Zelda

Zelda will use the exclusive data information to design a series of Phase 2 human clinical trials

Zelda aims to focus initial Phase 2 clinical trials around sleep disorders and dermatology indications. These include insomnia and acne respectively




Capital Structure on listing

Zelda would have 669m shares in total on issue, @ an IPO price of $0.025 per share,

That will give it a market cap of appx $17 M AUD.

160m shares were offered as new shares raised $4m AUD in total.

Old GLN.ASX holders were given a 1:5 consolidation converting $0.005 per share to $0.025.






TOP 20 & Initial Directors Interests

Four members of board directors are now top 5 holders of the company, with details below:





And a little bit info about Dr Stewart Washer:

He is currently Executive Chairman of CYP.ASX & OCC.ASX, two mid tier bio-tech listed companies in ASX.





marijuana is now legal in California